Cargando…
Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal malignancies. Development of the chemoresistance in the PDAC is one of the key contributors to the poor survival outcomes and the major reason for urgent development of novel pharmacological approaches in a treatment of...
Autores principales: | Djokovic, Nemanja, Djuric, Ana, Ruzic, Dusan, Srdic-Rajic, Tatjana, Nikolic, Katarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964546/ https://www.ncbi.nlm.nih.gov/pubmed/37259439 http://dx.doi.org/10.3390/ph16020294 |
Ejemplares similares
-
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
por: Ruzic, Dusan, et al.
Publicado: (2022) -
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation
por: Ruzic, Dusan, et al.
Publicado: (2022) -
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
por: Gagic, Zarko, et al.
Publicado: (2020) -
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
por: Beljkas, Milan, et al.
Publicado: (2023) -
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells
por: Bulut, Ipek, et al.
Publicado: (2022)